NCT05598281View on ClinicalTrials.gov

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

November 19, 2019

Study Completion Date

November 19, 2019

Conditions

Healthy Participants

Interventions

DRUG

AMG 510

Oral tablet

DRUG

Digoxin

Oral tablet

Trial Locations (1)

32117

Covance Clinical Research Unit, Inc, Daytona Beach

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT05598281 - Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants | Biotech Hunter | Biotech Hunter